Overall, these findings highlight a convergent mitochondrial-proteostasis dysfunction axis in AD and suggest COX5B, ENO1, HSP90AB1, and SDHB as promising multi-target nodes for polyphenol-based therapeutic strategies. Here, ENO1 is linked to Alzheimer disease.